Baudax Bio Inc. (BXRX)
NASDAQ: BXRX
· Real-Time Price · USD
0.02
-0.00 (-1.48%)
At close: Feb 29, 2024, 9:53 PM
Baudax Bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 30K | -14K | 310K | 238K | 300K | 422K | 400K | 281K | 201K | 198K |
Cost of Revenue | 43K | 104K | 405K | 4.79M | 1.21M | 361K | 648K | 576K | 462K | 586K | 821K |
Gross Profit | -43K | -74K | -419K | -4.48M | -970K | -61K | -226K | -176K | -181K | -385K | -623K |
Operating Income | -1.78M | -7.04M | -4.69M | -8.6M | 16.56M | -6.97M | -12.54M | 30.01M | -16.38M | -16.32M | -16.32M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.78M | -7.3M | -7.39M | -9.25M | -29.2M | -7.53M | -12.81M | 29.43M | -16.96M | -15.33M | -16.91M |
Net Income | -1.93M | -7.38M | 11.4M | -9.25M | -29.2M | -7.53M | -12.81M | 29.43M | -16.96M | -15.33M | -16.91M |
Selling & General & Admin | 3.64M | 2.25M | 1.77M | 2.09M | 3.81M | 4.03M | 14.19M | 11.54M | 11.07M | 10.61M | 12.09M |
Research & Development | 1.9M | 1.78M | 2.92M | 1.04M | 645K | 912K | 1.29M | 502K | 658K | 857K | 1.11M |
Other Expenses | -115K | -256K | -2.7M | 65K | 644K | 644K | 644K | 1K | -582K | 987K | 644K |
Operating Expenses | 5.54M | 4.03M | 4.69M | 3.19M | 5.1M | 5.58M | 16.13M | 12.69M | 12.38M | 12.11M | 13.84M |
Interest Expense | n/a | n/a | n/a | 921K | 45.26M | 2.65M | n/a | 579K | n/a | n/a | 590K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.54M | 4.03M | 4.69M | 7.99M | 6.3M | 5.95M | 16.77M | 13.26M | 12.84M | 12.7M | 14.66M |
Income Tax Expense | 158K | 3.09M | 206K | 1.57M | 509K | 559K | 264K | -2.89M | 3.82M | 3.82M | 590K |
Shares Outstanding (Basic) | 7.99M | 4.89M | 2.32M | 1.62M | 295.9K | 179.54K | 160.32K | 60.53K | 60.28K | 53.43K | 44.7K |
Shares Outstanding (Diluted) | 7.99M | 4.89M | 2.32M | 1.62M | 295.9K | 179.54K | 160.32K | 60.53K | 60.28K | 53.45K | 44.7K |
EPS (Basic) | -0.24 | -1.51 | 4.91 | -5.7 | -98.7 | -41.95 | -79.89 | 446.40 | -281.2 | -286.8 | -378.4 |
EPS (Diluted) | -0.24 | -1.51 | 4.91 | -5.7 | -98.7 | -41.95 | -79.89 | 401.20 | -281.2 | -287.2 | -378.4 |
EBITDA | -43K | -74K | -4.68M | -6.69M | -6.03M | -3.76M | -15.71M | -2.91M | -16.38M | -16.32M | -16.32M |
EBIT | n/a | n/a | -23.68M | -8.33M | 16.05M | -4.88M | -23.59M | 17.93M | n/a | n/a | n/a |
Depreciation & Amortization | 131K | 1K | 3K | 1.91M | 683K | 3.34M | -6.93M | 644K | 690K | 707K | 730K |